Effect of Acute Increases of Intraocular Pressure on Corneal Pachymetry in Eyes Treated with Travoprost: An Animal Study

REFERENCES

•  Kass MA, Heuer DK, Higginbotham EJ et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 2002;120:701–13; discussion 829.
   Google Scholar
•  Francis BA, Varma R, Chopra V, Lai MY, Shtir C, Azen SP; Los Angeles Latino Eye Study Group. Intraocular pressure, central corneal thickness, and prevalence of open-angle glaucoma: the Los Angeles Latino Eye Study. Am J Ophthalmol 2008;146:741–746.
   PubMed Web of Science ®Google Scholar
•  Herndon LW, Weizer JS, Stinnett SS. Central corneal thickness as a risk factor for advanced glaucoma damage. Arch Ophthalmol 2004;122:17–21.
   PubMed Web of Science ®Google Scholar
•  Medeiros FA, Sample PA, Zangwill LM, Bowd C, Aihara M, Weinreb RN. Corneal thickness as a risk factor for visual field loss in patients with preperimetric glaucomatous optic neuropathy. Am J Ophthalmol 2003;136:805–813.
   PubMed Web of Science ®Google Scholar
•  Francis BA, Hsieh A, Lai MY et al.; Los Angeles Latino Eye Study Group. Effects of corneal thickness, corneal curvature, and intraocular pressure level on Goldmann applanation tonometry and dynamic contour tonometry. Ophthalmology 2007;114:20–26.
   PubMed Web of Science ®Google Scholar
•  Gordon MO, Beiser JA, Brandt JD et al. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol 2002;120:714–20; discussion 829.
   Google Scholar
•  Toh T, Liew SH, MacKinnon JR et al. Central corneal thickness is highly heritable: the twin eye studies. Invest Ophthalmol Vis Sci 2005;46:3718–3722.
   PubMed Web of Science ®Google Scholar
•  Zheng Y, Huang G, Huang W, He M. Distribution of central and peripheral corneal thickness in Chinese children and adults: the Guangzhou twin eye study. Cornea 2008;27:776–781.
   Google Scholar
•  Hamilton KE, Pye DC. Young’s modulus in normal corneas and the effect on applanation tonometry. Optom Vis Sci 2008;85:445–450.
   PubMed Web of Science ®Google Scholar
• Kotecha A. What biomechanical properties of the cornea are relevant for the clinician? Surv Ophthalmol 2007;52 Suppl 2:S109–S114.
   Google Scholar
• Teus MA, Bolívar G, Alió JL, Lipshitz I. Short-term effect of topical dorzolamide hydrochloride on intrastromal corneal pressure in rabbit corneas in vivo. Cornea 2009;28:206–210.
   Google Scholar
• Harasymowycz PJ, Papamatheakis DG, Ennis M, Brady M, Gordon KD; Travoprost Central Corneal Thickness Study Group. Relationship between travoprost and central corneal thickness in ocular hypertension and open-angle glaucoma. Cornea 2007;26:34–41.
   PubMed Web of Science ®Google Scholar
• Lindsey JD, Kashiwagi K, Kashiwagi F, Weinreb RN. Prostaglandin action on ciliary smooth muscle extracellular matrix metabolism: implications for uveoscleral outflow. Surv Ophthalmol 1997;41 Suppl 2:S53–S59.
   Google Scholar
• Honda N, Miyai T, Nejima R et al. Effect of latanoprost on the expression of matrix metalloproteinases and tissue inhibitor of metalloproteinase 1 on the ocular surface. Arch Ophthalmol 2010;128:466–471.
   PubMedGoogle Scholar
• Gaton DD, Sagara T, Lindsey JD, Gabelt BT, Kaufman PL, Weinreb RN. Increased matrix metalloproteinases 1, 2, and 3 in the monkey uveoscleral outflow pathway after topical prostaglandin F(2 alpha)-isopropyl ester treatment. Arch Ophthalmol 2001;119:1165–1170.
   PubMed Web of Science ®Google Scholar
• Lindsey JD, Crowston JG, Tran A, Morris C, Weinreb RN. Direct matrix metalloproteinase enhancement of transscleral permeability. Invest Ophthalmol Vis Sci 2007;48:752–755.
   Google Scholar
• Weinreb RN, Kashiwagi K, Kashiwagi F, Tsukahara S, Lindsey JD. Prostaglandins increase matrix metalloproteinase release from human ciliary smooth muscle cells. Invest Ophthalmol Vis Sci 1997;38:2772–2780.
   PubMed Web of Science ®Google Scholar
• Wierzbowska J, Stankiewicz A. [Topical prostaglandins influence over cornea–preliminary report]. Klin Oczna 2006;108:479–481.
   Google Scholar
• Bergonzi C, Giani A, Blini M, Marchi S, Luccarelli S, Staurenghi G. Evaluation of prostaglandin analogue effects on corneal keratocyte density using scanning laser confocal microscopy. J Glaucoma 2010;19:617–621.
   Google Scholar
• Agarwal DR, Ehrlich JR, Shimmyo M, Radcliffe NM. The relationship between corneal hysteresis and the magnitude of intraocular pressure reduction with topical prostaglandin therapy. Br J Ophthalmol 2011.
   Google Scholar
• Ang GS, Bochmann F, Townend J, Azuara-Blanco A. Corneal biomechanical properties in primary open angle glaucoma and normal tension glaucoma. J Glaucoma 2008;17:259–262.
   PubMed Web of Science ®Google Scholar
• Bonatti JA, Bechara SJ, Carricondo PC, Kara-José N. Proposal for a new approach to corneal biomechanics: dynamic corneal topography. Arq Bras Oftalmol 2009;72:264–267.
   Google Scholar
• Elsheikh A, Alhasso D, Kotecha A, Garway-Heath D. Assessment of the ocular response analyzer as a tool for intraocular pressure measurement. J Biomech Eng 2009;131:081010.
   Web of Science ®Google Scholar
• Elsheikh A, Wang D, Pye D. Determination of the modulus of elasticity of the human cornea. J Refract Surg 2007;23:808–818.
   PubMed Web of Science ®Google Scholar
• Liu J, Roberts CJ. Influence of corneal biomechanical properties on intraocular pressure measurement: quantitative analysis. J Cataract Refract Surg 2005;31:146–155.
   PubMed Web of Science ®Google Scholar
• Luce DA. Determining in vivo biomechanical properties of the cornea with an ocular response analyzer. J Cataract Refract Surg 2005;31:156–162.
   PubMed Web of Science ®Google Scholar
• Dawson DG, Schmack I, Holley GP, Waring GO 3rd, Grossniklaus HE, Edelhauser HF. Interface fluid syndrome in human eye bank corneas after LASIK: causes and pathogenesis. Ophthalmology 2007;114:1848–1859.
   Web of Science ®Google Scholar
• Hernandez-Verdejo JL, Teus MA, Bolivar G. Simultaneous measurement of intraocular pressure in the anterior chamber and the vitreous cavity. Acta Ophthalmol. England: 2009 The Authors. Journal compilation 2009 Acta Ophthalmol 2010:e265–268.
   Google Scholar
• Doughty MJ, Zaman ML. Human corneal thickness and its impact on intraocular pressure measures: a review and meta-analysis approach. Surv Ophthalmol 2000;44:367–408.
   PubMed Web of Science ®Google Scholar
• Weizer JS, Stinnett SS, Herndon LW. Longitudinal changes in central corneal thickness and their relation to glaucoma status: an 8 year follow up study. Br J Ophthalmol 2006;90:732–736.
   PubMed Web of Science ®Google Scholar
• Klyce SD. Stromal lactate accumulation can account for corneal oedema osmotically following epithelial hypoxia in the rabbit. J Physiol (Lond) 1981;321:49–64.
   Google Scholar
• Hennighausen H, Feldman ST, Bille JF, McCulloch AD. Anterior-posterior strain variation in normally hydrated and swollen rabbit cornea. Invest Ophthalmol Vis Sci 1998;39:253–262.
   Google Scholar
• Dada T, Konkal V, Tandon R, Singh R, Sihota R. Corneal topographic response to intraocular pressure reduction in patients with vernal keratoconjunctivitis and steroid-induced glaucoma. Eye (Lond) 2007;21:158–163.
   Google Scholar
• Hiatt JA, Wachler BS, Grant C. Reversal of laser in situ keratomileusis-induced ectasia with intraocular pressure reduction. J Cataract Refract Surg 2005;31:1652–1655.
   PubMed Web of Science ®Google Scholar
• Lass JH, Eriksson GL, Osterling L, Simpson CV; Latanoprost Corneal Effects Study Group. Comparison of the corneal effects of latanoprost, fixed combination latanoprost-timolol, and timolol: A double-masked, randomized, one-year study. Ophthalmology 2001;108:264–271.
   PubMed Web of Science ®Google Scholar
• Sen E, Nalcacioglu P, Yazici A et al. Comparison of the effects of latanoprost and bimatoprost on central corneal thickness. J Glaucoma 2008;17:398–402.
   PubMed Web of Science ®Google Scholar
• Bafa M, Georgopoulos G, Mihas C, Stavrakas P, Papaconstantinou D, Vergados I. The effect of prostaglandin analogues on central corneal thickness of patients with chronic open-angle glaucoma: a 2-year study on 129 eyes. Acta Ophthalmol 2011;89:448–451.
   Google Scholar
• Toris CB, Gabelt BT, Kaufman PL. Update on the mechanism of action of topical prostaglandins for intraocular pressure reduction. Surv Ophthalmol 2008;53 Suppl1:S107–S120.
   Google Scholar
• Mietz H, Esser JM, Welsandt G et al. Latanoprost stimulates secretion of matrix metalloproteinases in tenon fibroblasts both in vitro and in vivo. Invest Ophthalmol Vis Sci 2003;44:5182–5188.
   PubMed Web of Science ®Google Scholar
• Weinreb RN, Lindsey JD, Marchenko G, Marchenko N, Angert M, Strongin A. Prostaglandin FP agonists alter metalloproteinase gene expression in sclera. Invest Ophthalmol Vis Sci 2004;45:4368–4377.
   PubMed Web of Science ®Google Scholar
• Gutiérrez-Ortiz C, Teus MA, Bolivar G. Short-term effects of latanoprost on anterior chamber depth in patients with glaucoma or ocular hypertension. Invest Ophthalmol Vis Sci 2006;47:4856–4859.
   Google Scholar
• Lema I, Durán JA. Inflammatory molecules in the tears of patients with keratoconus. Ophthalmology 2005;112:654–659.
   PubMed Web of Science ®Google Scholar
• Amano S, Nakai Y, Ko A, Inoue K, Wakakura M. A case of keratoconus progression associated with the use of topical latanoprost. Jpn J Ophthalmol 2008;52:334–336.
   PubMed Web of Science ®Google Scholar
• Liu Y, Yanai R, Lu Y, Hirano S, Sagara T, Nishida T. Effects of antiglaucoma drugs on collagen gel contraction mediated by human corneal fibroblasts. J Glaucoma 2006;15:255–259.
   PubMed Web of Science ®Google Scholar